Emet Surgical

Company Overview

Snapshot

Founded in February 2021 by Bob Witkow, Emet Surgical operates with 1–10 employees. The company has raised $1.3M across three funding rounds. In May 2024, Emet Surgical secured a grant from Inspiranto Innovation Fund, highlighting ongoing support for its innovative surgical precision system.

Business overview

Emet Surgical is dedicated to redefining minimally invasive surgery through its ESP (Enhanced Surgical Precision) system. This AI/ML-powered platform provides real-time surgical guidance and cancerous tissue recognition, aiming to enhance precision and decision-making for surgeons. The company's technology integrates with existing robotic or laparoscopic systems, addressing challenges such as reducing complications and reoperations, and reversing the decline in incidental cancer detection. Emet Surgical operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Medical Devices, serving healthcare providers and hospitals with its B2B business model.

Strategic signal

In April 2023, Emet Surgical announced its aspiration to improve surgery outcomes by fostering true collaboration between cancer surgeons and pathologists. This initiative signals a strategic focus on integrating advanced technology with medical expertise to address critical challenges in cancer treatment, indicating a commitment to enhancing diagnostic accuracy and surgical efficacy through data-driven insights.

Company Intelligence Q&A

What is Emet Surgical's core product?

Emet Surgical's core product is the ESP (Enhanced Surgical Precision) system, an AI/ML-powered platform designed to provide real-time surgical guidance and cancerous tissue recognition during minimally invasive procedures.

When was Emet Surgical founded and by whom?

Emet Surgical was founded in February 2021 by Bob Witkow.

What significant funding did Emet Surgical receive in 2022?

In February 2022, Emet Surgical received an investment from Bob Witkow, who contributed $1,000,000.

What grant did Emet Surgical secure in 2024?

In May 2024, Emet Surgical secured a grant from Inspiranto Innovation Fund. This grant supports the company's innovative surgical precision system, which uses AI/ML to provide real-time surgical guidance and cancerous tissue recognition.

What is Emet Surgical's strategic focus regarding surgical outcomes?

In April 2023, Emet Surgical announced its aspiration to improve surgery outcomes by enabling true collaboration between cancer surgeons and pathologists, leveraging its technology for enhanced precision and decision-making.